Genetic Markers of Circulating Tumor DNA for Monitoring Breast Cancer Patients in Costa Rica
NCT04163159 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2019-11-25
Summary
The use of circulating tumor DNA (ctDNA) as a noninvasive test for breast cancer monitoring throughout the course of the disease
Conditions
- Metastatic Breast Cancer
- Mutation, Point
Sponsors & Collaborators
-
Universidad de Costa Rica
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-07
- Primary Completion
- 2020-10-31
- Completion
- 2020-11-30
Countries
- Costa Rica
Study Locations
More Related Trials
-
Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer
NCT05427617 ·Status: COMPLETED
-
Knowledge and Attitudes of Patients and Healthcare Professionals on a Spectrum of Genetic Tests Relevant to Breast Cancer Patients
NCT01619306 ·Status: UNKNOWN
-
Circulating Tumor DNA as Marker of Therapeutic Efficacy in Breast Cancer Patients
NCT03881384 ·Status: UNKNOWN
-
Clinical Application of CTDNA in Operable Breast Cancer Patients
NCT02797652 ·Status: UNKNOWN
-
Potential of Circulating Tumor DNA to Assess the Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
NCT03688035 ·Status: UNKNOWN
-
Discerning the Impact of ctDNA Detection on Patient Decision Making in Early Stage Breast Cancer: a Conjoint Analysis
NCT05730010 ·Status: COMPLETED
-
Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy
NCT03709134 ·Status: COMPLETED
-
Prognostic Value of Circulating Tumor DNA Dosing in Patients in Neoadjuvant Breast Neoplasia
NCT05050890 ·Status: UNKNOWN
-
Evaluating Whether Integration of Prognostic and Predictive Algorithms Into Routine Clinical Practice Effect Whether Oncologists Order Multigene Assays in Patients With Early Stage Breast Cancer
NCT04131933 ·Status: COMPLETED
-
Plasma Circulating Tumor DNA Analyses in ER+ Metastatic Breast Cancer
NCT03161834 ·Status: WITHDRAWN
-
Study on Early Auxiliary Diagnosis and Postoperative Recurrence Monitoring of Breast Cancer
NCT05858242 ·Status: RECRUITING
-
Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment
NCT06087120 ·Status: RECRUITING
-
The Immune System's Response to Young Women's Breast Cancer
NCT01503190 ·Status: RECRUITING
-
Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer
NCT01514565 ·Status: UNKNOWN
-
Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer
NCT04920656 ·Status: COMPLETED
-
Circulating Tumor DNA and Immunophenotyping as Potential Biomarkers With Regional Nodal Irradiation for Breast Cancer
NCT04308720 ·Status: ACTIVE_NOT_RECRUITING
-
Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer
NCT06876610 ·Status: RECRUITING
-
Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging
NCT05809128 ·Status: UNKNOWN
-
Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer
NCT02743910 ·Status: ACTIVE_NOT_RECRUITING
-
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
NCT01000883 ·Status: RECRUITING
-
Molecular Analysis of Breast Cancer
NCT00569049 ·Status: COMPLETED
-
A Study to Develop Molecular Integrated Predictive Models of Breast Radio-toxicity (Precise-RTox)
NCT06114589 ·Status: RECRUITING
-
Clinical Application of ctDNA in Early Screening of Breast Cancer
NCT03973034 ·Status: UNKNOWN
-
Exploring a Breast Cancer Early Screening Model Based on cfDNA
NCT06016790 ·Status: COMPLETED
-
Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy
NCT00897299 ·Status: COMPLETED